http://www.biooncology.com/research-...-dimerization/
HER2 dimerization: a key component of oncogenic signaling in HER2+ breast cancer
The HER family
The HER family is composed of 4 receptor tyrosine kinases that must pair, or dimerize, to activate downstream signaling
1:
- EGFR (HER1)
- HER2
- HER3
- HER4
The role of dimerization in HER2+ disease
Preclinical studies indicate that HER dimerization, or receptor pairing, is a critical step in HER activation.
1 While the receptors of the HER family are important mediators of normal cell growth and development, HER activation has also been implicated in cancer development and progression.
10
In normal cell growth, dimerization is an essential requirement of HER functionality and signaling, and it occurs between 2 of the same receptors (homodimerization) or 2 different receptors (heterodimerization).
1
However, in HER2+ disease, HER2 overexpression is associated with excessive dimerization that contributes to cell survival, cell proliferation, and tumorigenesis.
6
The HER family of receptors.
Ligand binding and HER activation
Each HER family receptor has 3 domains: the extracellular, transmembrane, and intracellular domains, all of which are necessary for receptor activation and intracellular signaling. In order to activate downstream signaling, receptors must dimerize utilizing the dimerization sub-domain (known as sub-domain II) located on the extracellular domain of the receptor.
10
EGFR (HER1), HER3, and HER4 naturally exist in a “closed” conformation. In the closed position, the dimerization sub-domain (sub-domain II) is hidden or inaccessible, and as a result, the receptor is unable to form dimers. Ligand binding to these receptors leads to a conformational change, exposing sub-domain II and enabling the receptor to dimerize and initiate downstream signaling. HER2 is the only receptor in the HER family that exists in a continuously open conformation ready to dimerize without the need for ligand binding.
3,11
HER2 dimerization: critical for tumor growth
When HER family members dimerize, the intracellular domains of the paired receptors are phosphorylated, resulting in the activation of cell proliferation and cell survival pathways.
12
In HER2+ disease, the overexpression of HER2 is associated with overactive HER2 dimerization, abnormal signaling, and ultimately tumor growth.
6
Dimerization: an important driver of oncogenic signaling
Please note: this video contains sound so please adjust volume
